Edmolin.com

Informed Today Influential Tomorrow

Health Fitness

Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidys

The regulator had asked Sarepta Therapeutics to halt all shipments of its therapy, Ele­vidys, after three patients died from liver failure after taking it or a similar treatment.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *